Related Experiment Video
Updated: Dec 30, 2025

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Cutting Edge: The RNA-Binding Protein Ewing Sarcoma Is a Novel Modulator of Lymphotoxin β Receptor Signaling
Richard Virgen-Slane1, Ricardo G Correa1, Parham Ramezani-Rad2
1Laboratory of Molecular Immunology, Infectious and Inflammatory Diseases Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.
Abstract:
Lymphotoxin β receptor (LTβR) signaling is crucial for lymphoid tissue organogenesis and immune homeostasis. To identify novel regulatory mechanisms for signaling, we implemented a two-step screen that uses coexpression analysis of human fibroblasts undergoing LTβR stimulation and affinity-purification mass spectrometry for the LTβR signaling protein TNFR-associated factor 3 (TRAF3). We identify Ewing sarcoma (EWS) protein as a novel LTβR signaling component that associates with TRAF3 but not with TNFR-associated factor 2 (TRAF2). The EWS:TRAF3 complex forms under unligated conditions that are disrupted following activation of the LTβR. We conclude that EWS limits expression of proinflammatory molecules, GM-CSF, and ERK-2, promoting immune homeostasis.
Insights
Ewing sarcoma (EWS) protein regulates lymphotoxin β receptor (LTβR) signaling by interacting with TRAF3. This interaction limits pro-inflammatory molecule expression, promoting immune homeostasis.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Lymphotoxin β receptor (LTβR) signaling is essential for developing lymphoid tissues and maintaining immune balance.
- Understanding LTβR signaling regulation is key to controlling immune responses.
Purpose of the Study:
- To discover novel regulators of LTβR signaling.
- To elucidate the role of Ewing sarcoma (EWS) protein in LTβR pathway.
Main Methods:
- Coexpression analysis of human fibroblasts stimulated via LTβR.
- Affinity-purification mass spectrometry targeting TNFR-associated factor 3 (TRAF3).
Main Results:
- Ewing sarcoma (EWS) protein identified as a novel LTβR signaling component.
- EWS specifically associates with TRAF3, not TRAF2.
- The EWS:TRAF3 complex forms before LTβR activation and dissociates upon stimulation.
Conclusions:
- EWS acts as a negative regulator in the LTβR pathway.
- EWS limits the expression of pro-inflammatory molecules like GM-CSF and ERK-2.
- EWS contributes to maintaining immune homeostasis through LTβR signaling modulation.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Canonical Wnt Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

